Skip to main content
Caplight Logo









OrientaMED

OrientaMED

Private
Feira de SantanaHealthcare & Life Scienceshttps://orientamed.bio/

Last Round

Grant

Aug 2, 2022

Total Funding Raised

$31,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OrientaMED is a biotechnology company that develops non-invasive, portable diagnostic devices using artificial intelligence to detect diseases through exhaled breath analysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

breath analysisnon-invasive glucose monitoringbreathalyzerdigital healthmedical devicediabetes managementhealth IoTremote patient monitoringRPMdeep learningbiomarker detectionpoint-of-care diagnosticsPOC diagnosticshardware-as-a-serviceHaaSneedle-free testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrientaMED Comparables

Compare OrientaMED with similar companies based on industry and business-model similarity.

OrientaMED comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BOYDSense
83%
PKvitality
78%
RSP Systems A/S
76%

OrientaMED Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 2, 2022
AcceleratorSep 22, 2021
AcceleratorDec 6, 2018

OrientaMED Investors

Notable investors and investment history

OrientaMED investors
InvestorRounds
FAPERJAccelerator
Poland PrizeAccelerator
Biominas BrasilAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 615% MoM, from 46 to 329.

  • Aug 2, 2022

    Secured $5K in grant funding.

OrientaMED Filings

Explore SEC and related filing metadata, where available.

OrientaMED filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OrientaMED's valuation, stock price, and market status.

Is OrientaMED a public or private company?

OrientaMED is a private company.

What is the current stock price of OrientaMED?

OrientaMED is a private company with no public stock price. No recent secondary market data is available.

How much is OrientaMED worth (valuation)?

Valuation information for OrientaMED is not publicly available.

Can I buy OrientaMED stock?

OrientaMED shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OrientaMED's last funding round?

OrientaMED's most recent funding round was Grant on August 2, 2022.

Who are the main investors in OrientaMED?

Key investors in OrientaMED include FAPERJ, Poland Prize, Biominas Brasil.

Will OrientaMED IPO soon?

No public IPO plans have been announced for OrientaMED.

How can I track OrientaMED secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrientaMED's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFeira de Santana
Employee Range4
Year Founded2018
Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?